{
    "root": "11e27a6a-20dd-49aa-8032-16d79d3eb875",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Celecoxib",
    "value": "20250501",
    "ingredients": [
        {
            "name": "CELECOXIB",
            "code": "JCX84Q7J1L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_41423"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        }
    ],
    "indications": {
        "text": "celecoxib indicated",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 lowest effective shortest duration consistent individual patient treatment goals . ( error ! hyperlink reference valid . ) \u2022 oa : 200 mg daily 100 mg twice daily . ( error ! hyperlink reference valid . , error ! hyperlink reference valid . ) \u2022 rheumatoid arthritis : 100 mg 200 mg twice daily . ( error ! hyperlink reference valid . , error ! hyperlink reference valid . ) \u2022 jra : 50 mg twice daily patients 10 kg 25 kg . 100 mg twice daily patients 25 kg . ( error ! hyperlink reference valid . , error ! hyperlink reference valid . ) \u2022 : 200 mg daily single dose 100 mg twice daily . effect observed 6 weeks , trial 400 mg ( single divided doses ) may benefit . ( error ! hyperlink reference valid . , error ! hyperlink reference valid . ) \u2022 ap pd : 400 mg initially , followed 200 mg dose needed first day . subsequent days , 200 mg twice daily needed . ( error ! hyperlink reference valid . , error ! hyperlink reference valid . ) hepatic impairment : reduce daily dose 50 % patients moderate hepatic impairment ( child-pugh class b ) . ( error ! hyperlink reference valid . , error ! hyperlink reference valid . , error ! hyperlink reference valid . ) poor metabolizers cyp2c9 substrates : consider dose reduction 50 % ( alternative management jra ) patients known suspected cyp2c9 poor metabolizers . ( error ! hyperlink reference valid . , error ! hyperlink reference valid . , error ! hyperlink reference valid . )",
        "doid_entities": [
            {
                "text": "rheumatoid arthritis (DOID:7148)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7148"
            },
            {
                "text": "arthritis (DOID:848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_848"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "celecoxib 200 mg capsules white , `` oe `` imprinted cap `` 200 `` body , supplied : ndc 82804-213-30 bottle 30 ndc 82804-213-60 bottle 60 ndc 82804-213-90 bottle 90",
    "adverseReactions": "celecoxib contraindicated following patients : \u2022 known hypersensitivity ( e.g . , anaphylactic serious skin ) celecoxib , components product [ error ! hyperlink reference valid . , error ! hyperlink reference valid . ] . \u2022history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids , reported patients [ error ! hyperlink reference valid . , error ! hyperlink reference valid . ] . \u2022in setting cabg surgery [ error ! hyperlink reference valid . ] . \u2022in patients demonstrated allergic-type sulfonamides [ error ! hyperlink reference valid . ] .",
    "indications_original": "Celecoxib is indicated",
    "contraindications_original": "\u2022 Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. ( Error! Hyperlink reference not valid. ) \u2022 OA: 200 mg once daily or 100 mg twice daily. ( Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. ) \u2022 RA: 100 mg to 200 mg twice daily. ( Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. ) \u2022 JRA: 50 mg twice daily in patients 10 kg to 25 kg. 100 mg twice daily in patients more than 25 kg. ( Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. ) \u2022 AS: 200 mg once daily single dose or 100 mg twice daily. If no effect is observed after 6 weeks, a trial of 400 mg (single or divided doses) may be of benefit. ( Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. ) \u2022 AP and PD: 400 mg initially, followed by 200 mg dose if needed on first day. On subsequent days, 200 mg twice daily as needed. ( Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. ) Hepatic Impairment: Reduce daily dose by 50% in patients with moderate hepatic impairment (Child-Pugh Class B). ( Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. ) Poor Metabolizers of CYP2C9 Substrates: Consider a dose reduction by 50% (or alternative management for JRA) in patients who are known or suspected to be CYP2C9 poor metabolizers. ( Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. , Error! Hyperlink reference not valid. )",
    "warningsAndPrecautions_original": "Celecoxib 200 mg capsules are white, with \"OE\" imprinted on the cap and \"200\" on the body, supplied as:\n                  \n                     \n                     \n                     \n                        \n                           \n                              NDC 82804-213-30\n                           \n                           \n                              bottle of 30\n                           \n                        \n                        \n                           \n                              NDC 82804-213-60\n                           \n                           \n                              bottle of 60\n                           \n                        \n                        \n                           \n                              NDC 82804-213-90\n                           \n                           \n                              bottle of 90",
    "adverseReactions_original": "Celecoxib is contraindicated in the following patients:\n                  \n                  \n                     \n                        \u2022\n                        Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see \n                           Error! Hyperlink reference not valid.\n                           , \n                           Error! Hyperlink reference not valid.].\n                     \n                     \n                        \u2022History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs, have been reported in such patients [see \n                        Error! Hyperlink reference not valid.\n                        , \n                        Error! Hyperlink reference not valid.].\n                     \n                        \u2022In the setting of CABG surgery [see \n                        Error! Hyperlink reference not valid.].\n                     \n                        \u2022In patients who have demonstrated allergic-type reactions to sulfonamides [see \n                        Error! Hyperlink reference not valid.].",
    "drug": [
        {
            "name": "Celecoxib",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_41423"
        }
    ]
}